0.42
Apimeds Pharmaceuticals US, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
0.01
FY25:
14.0
(positive)
millions USD
FY23:
0
FY24:
0
FY25:
150
Total assets
Change from FY23 to FY25
millions USD
FY23:
0.42
FY24:
0.01
FY25:
164
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.12
FY24:
1.02
FY25:
10.7
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.27
FY24:
0.35
FY25:
0.13
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.03
FY24:
−1.36
FY25:
153
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
0.42
FY24:
0.01
FY25:
164
All amounts in millions USD